Saroglitazar magnesium 4 mg

( DrugBank: Saroglitazar, Magnesium / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
93	Primary biliary cholangitis	1

93. Primary biliary cholangitis

Clinical trials : 298 / Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03112681 (ClinicalTrials.gov)	August 18, 2017	10/4/2017	Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Bili ...	A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate ...	Primary Biliary Cirrhosis	Drug: Saroglitazar magnesium 2 mg;Drug: Saroglitazar magnesium 4 mg;Drug: Placebo Oral Tablet	Zydus Discovery DMCC	NULL	Active, not recruiting	18 Years	75 Years	All	37	Phase 2	United States

First Previous1Next Last